Introduction
In the analysis of China's industrial reforms, attention has focused on the increasing losses and declining role of the state sector. However, this picture conceals a continuing, indeed increasing, role for big business.
The emergence of the fast-growing market economy in China after 1978 provided opportunities for traditional large plants to grow into more complex big businesses, stimulated especially by booming demand for their upstream products, such as steel and petrochemicals (Nolan, 1995 (Nolan, , 1996 . However, large firms emerged also from among the ranks of new entrants and small producers. With the exception of excellent but rather outdated research conducted by Byrd (1992 Byrd ( ) in 1983 Byrd ( -1985 , there is negligible analysis of the institutional process of the emergence of large Chinese firms under system reform. This paper presents a case study of two such firms, one of each type. The Shougang Group (hereinafter Shougang) is a traditional state-owned enterprise (SOE) which grew into the third largest steel plant while the Sanjiu Group (hereinafter Sanjiu) is a new entrant who became the second largest pharmaceutical plant in China. These firms are strongly shaped by the peculiarities of the Chinese institutional setting. The findings of this paper have profound implications for the development of large enterprises and the SOE reforms in China.
The background of the Chinese steel and pharmaceuticals industries is briefly reviewed in sections 2 and 4 before the analysis of Shougang and Sanjiu in sections 3 and 5. Section 6 concludes the major findings of this paper.
The Chinese Steel Industry in Reform
As a traditional strategic industry, the Ministry of Metallurgy Industry (MMI) controlled the overall development of the Chinese steel industry until the late 1980s. In 1997, the MMI was abolished, and replaced by the State Bureau of Metallurgical Industry (SBMI). Despite having delegated many of its functions to the provincial level, the SBMI still retained important planning functions and an influence over key steel policies. With the exception of Shougang (which reports directly to the Beijing municipal government), the other largest Chinese steelmakers all report directly to the SBMI.
Throughout the 1980s, steel prices and product mix were controlled by the government. The government continued to fix "guidance" prices for the main steel products, even though it freed all steel prices in 1994. The price control and excess demand led to a considerable disparity between planned and market prices of steel, e.g. 1,200-1,400 yuan of planned price for reinforced steels versus up to 3,100 yuan of market price in 1992. In 1998, faced with the sharp decline both in steel prices and industry profitability, the government introduced price floors for steel products temporarily to support the industry's profits. At present, there are few restrictions on the product mix or choice of customer for China's large integrated steel plants.
In its efforts to gain admission to the World Trade Organisation (WTO), China sharply reduced tariffs on steel imports. Overall import tariffs on iron and steel (raw and finished) fell from 23.8% in 1992 to 12% in 1996. Import tariffs varied from a low of 1.4% on pig iron to a high of 20.3% on stainless steel bars and rods. By 1996, the licensing system was ended. However, new non-tariff barriers to protect the steel industry from the explosion of steel imports were erected in the mid-1990s, e.g. import "registration" and "canalisation" of steel imports through selected SOEs (Dickson, 1996, pp. 98-99) .
The Chinese government has determined to develop the four leading steel enterprises -Baogang, Shougang, Angang and Wugang -into world-class companies, rivalling Nippon Steel and Posco for efficiency and global influence.
The strategy for the steel industry is part of the wider industrial policy of "grasping the large and letting go of the small" (zhuada, fangxiao). The Chinese government intends that by the year 2000, the four leading steel conglomerates will have increased their share of national steel output to 40%. As part of this policy, the central government has banned any new steel plant construction until the end of 2000 (SCMP, 28 October 1998) . Each of these four enterprises had an annual output of over five million tons in 1997, and accounted for 28% of China's total steel output. Their aggregate pre-tax profits in 1996 amounted to 4.4 billion yuan, equal to the profits for the entire Chinese steel industry. However, they were still not in the front ranks of the world's steel producers. China's highest-ranking steel enterprise in 1998 was Baogang, which ranked thirteenth. Angang ranked twentieth and Shougang twenty-first. Their level of labour productivity is far behind that of the world's leading steel firms. Apart from Baogang, their level of profitability is low: the ratio of profits to sales stood at 8.5% at Baogang, compared to less than 2% at Wugang, Shougang and Angang in 1997. In 1996, the proportion of steel products judged to be at the level of "advanced world standards" stood at 99% at Baogang, 81% at Wugang, 61% at Angang and just 29% at Shougang (ISIC, 1997; CMISI, 1998; IISI, 1999) .
Military-style Industrial Entrepreneurship: Shougang

The contract responsibility system
Shougang was run by a former People's Liberalisation Army (PLA) commander and senior figure in the Chinese Communist Party (CCP), Zhou Guanwu, until 1995.
1 It was one of the first pilot enterprises to undertake the contract responsibility system in 1979. Rather than being negotiated on an annual basis, a 15-year contract (1981-1995) was struck with the direct administrative superior of Shougang, namely the Beijing city government. The contract system adopted at Shougang consisted of four elements:
• Profits handed-over to the state were to increase by 7.2% annually -the base figure was the profit submitted in 1981. Any profits over this amount were retained by the enterprise.
• Of the retained profit, 60% was to be used as development funds, 20% as collective welfare funds, and 20% as bonuses for the employees: this was the 6:2:2 system.
• No financial assistance was to be forthcoming from the state and Shougang was to be responsible for its assets depreciation.
• The size of the wage-bill was linked to the enterprise's profits: for every 1% increase in profits there was to be a 0.8% rise in the payroll.
The contract system hardened the immediate financial pressure on Shougang. Each year, Shougang paid a state infrastructure tax, amounting to 15% of retained profits. Being proportionate to the enterprise's retained profits, these payments rose at a much faster rate than did the contracted profits hand-over.
Shougang made various other payments to the government, e.g. industrial and commercial tax, income tax, adjustment tax (tiaojie shui), and city construction tax (chengshi jianshe shui).
Autonomy within constraints
The managerial autonomy permitted to Shougang after 1978 was much less than that which farmers received under the contract system. State control was only relaxed gradually, and in many respects remained tight even in the mid- appointed by the Beijing city government. It may be more accurate to describe the "Board of Directors" (lishihui) as the "management team" or the executive directors. Shougang's real "Board of Directors" was the Beijing government, to whom the "preferred dividend" (in the form of profits hand-over) was paid.
Government control over Shougang's product prices and production structure gradually atrophied, only finally disappearing in the late 1990s.
Shougang was allowed to sell 15% of planned output (compared to 2% for ordinary enterprises in 1986-1987) and all output above the plan at up to 20% above planned prices (the 20% ceiling was abolished after 1988). Throughout the period 1985-1992, the proportion sold by Shougang to the free market was around one-third to one-half of total output. Shougang was, and still is, China's leading producer mainly at the lower value-added end of steel products, e.g. small section steel and wire rods. The competition was strongest from emerging, small-scale producers. In 1997, local and "non-system" (i.e. outside the planning framework) plants accounted for 69% of output of small section steel and 53% of the output of wire rods (CMISI, 1998, pp. 8-44) . These products benefited much less from economies of scale, often required less complex, lumpy equipment, and needed less attention to product quality.
The government still set the wage structure and the rights to make workers redundant.
2 Unlike Western steel firms, Shougang was forced to look towards growth rather than redundancy as the main path to solving the problem of surplus employees. In 1996, average annual wages (including bonuses and subsidies) in
Chinese keypoint steel plants stood at 10,507 yuan, compared to 10,136 yuan at Shougang, 10,230 yuan at Angang and 12,232 yuan at Wugang. Baogang alone among the large steel plants had substantially higher average wages at 25,000
yuan (ISIC, 1997, pp. 122-123; CMISI, 1998, pp. 276-280) . The wage structure in Shougang was based on three components: (1) basic wage, as determined by the worker's skill (accounted for 50% of income in 1993); (2) bonus, as determined by the monthly evaluation of the employee's performance (accounted for 30% of income); and (3) the year-on-year bonus, as determined by the overall performance of the enterprise (accounted for 20% of income).
Modernisation of the core steel-making business
In 1983, Shougang merged with 17 large profit-making steel-makers in Beijing, with a total of around 30,000 employees, under the directive of the city government. These factories, together with Shougang itself, form the backbone of the Shougang steel business (Li, et al., 1992, pp. 225-226) . However, Shougang faced the booming market demand with such outdated facilities that foreign visitors in the early years called it a "museum of metallurgical history". 3 It was imperative to both grow and modernise simultaneously.
Rather than needing prior approval for the purchase of any item valued above 800 yuan, Shougang was granted "complete autonomy" on the allocation of resources earmarked for investment, as long as it fulfilled its target for profits hand-over to the state. From 1980 to 1990, Shougang spent 4.27 billion yuan for technical renovation and capital construction on 108 key projects, all of them earning sufficient profits to recoup their investment outlays within two years (Li, et al., 1992) . In 1993, Shougang allocated 320 million yuan to research and development (R&D), equivalent to 2.5% of total sales value and 10% of total profits in that year. The main channel for Shougang's expansion in steel production after 1995 was intended to be through the planned construction of the new 10 million-ton plant, Qilu Iron and Steel in Shandong province. 4 Much of Shougang's diversification and transnationalisation in the later phase of the contract system was related to this goal.
• Machine-building capability: After the mergers of 20 large machinery enterprises and 13 military factories in 1988, the Shougang Heavy Machinery
Corporation was established to design and build machinery to meet the urgent metallurgical and mining needs generated by Shougang's growth. 5 It had 60,000 employees and more than 20 machinery plants scattered over eight provinces. It also exported metallurgical equipment, internal combustion engines, automobile components, hardware and tools, etc. (SG, 1995, p. 8; 1998, p. 2).
• Construction capacity: By 1992, Shougang had 10 construction companies, comprising the Shougang Construction Corporation, with a total of 80,000 employees. They were engaged in the construction, installation and commissioning of blast furnaces, power stations and other heavy auxiliary equipment relating to the steel industry.
• Design and electronic control capability: Shougang's technical capability was greatly extended after it acquired 70% of the Mesta Engineering (SG, 1998, p. 39) . In 1992, Shougang purchased the Hierro iron mine in Peru for US$120 million, originally intended to guarantee the supply of raw material for Qilu (Liu, et al., 1994) . It has 40 years of reserves at an annual rate of production of 15 million tons.
• Shipping capability: The high price of freight -which accounted for up to one-half of the total purchase price of second-hand equipment -led Shougang to set up a shipping JV with the Hong Kong Hongda Shipping Company. In 1990, the company merged with the Zhenjiang Shipping Company to form the Shougang Shipping and Ship Construction Company (SRDC, 1992, pp. 116-117) . By 1994, it had a total transportation capacity of 2.4 million tons.
• Export capability: Shougang spent US$20 million to purchase 51% of a steel trading company in Hong Kong, Tung Wing Iron and Steel Ltd. in 1992 (Wang, 1993, p. 207) . By 1993, Shougang controlled seven listed companies in Hong Kong, with US$1.54 billion worth of assets. In 1992, Shougang's foreign exchange earnings had reached US$350 million, accounting for 17% of Shougang's total revenue. It had become China's largest manufacturing exporter. tons of material and installing 25,000 tons of material. Over 7,000 workers were assigned to work day and night in a 100m 3 area. It was completed in 55 days rather than the 104 days that had originally been scheduled (BR, 13-19 January 1992, p. 16 ).
Military-style management methods
Renovation
The technological and financial imperatives led to each major renovation being treated as a battle, which tended to push the firm towards a highly centralised military style structure. The four necessary conditions for successful military-style organisation are as follows:
• A unified command system to plan and act as an integrated entity.
• Strict discipline, in order to meet severe technological requirements. If production targets were not fulfilled three months running, the work of senior staff was examined and those considered responsible were removed. The strict discipline also applied to cadres, e.g. 10% of Shougang's cadres at and above the level of subordinate plant and division management were either demoted (643) or dismissed (35) between 1978 and 1990 (Hao, 1992, p. 157; Xu & Liu, 1992, p. 217 ).
• Full mobilisation, in order to master new and imported technology at all levels. While the Corporation was responsible to the state, each of its subdivisions and each member of the staff knew their responsibility for the fulfilment of the overall output, profit and other economic and technical tasks.
The function of the internal contract system was to mobilise rather than to monitor, as the Taylorist monitoring/reward system does. It owed much more to the mobilisatory tradition of the CCP and the PLA than to study of Western management theory.
• A strong supporting service to support full mobilisation and the "battlefront". Shougang not only provided its employees with heavily subsidised housing, but also cheaper food, health care, daily-use commodities, kindergartens and martyrs' graves. The 20,000 employees in Shougang's Commission for Managing the Livelihood of Employees were required to support the collective effort, irrespective of the time or the day. This is analogous to the function of rear supply units in an army.
In contrast to the traditional theory of consumer economics and profit maximisation, Thurow (1991, p. 51) has argued that in Japan during its rise to global power in the 1980s, competition was treated as warfare rather than a rational process of profit maximisation. Janelli's (1993, p. 226) 
Shougang since the contract system
The contract system was discontinued after the completion of the 15-year contract in December 1995. After 1995, Shougang was technically supposed to pay profits taxes and turnover taxes as laid down by law. The Beijing government directly reimburses Shougang all of its profits tax, which amounted to around 70 million yuan in 1997 (on pre-tax profits of 351 million yuan). However, Shougang has to pay 10% of its total sales revenue as turnover tax to the Beijing government (around 1.7 billion yuan in 1996 and 1.8 billion yuan in 1997), which is much higher than the profits tax reimbursement, and several times higher than the total retained profits (180-200 million yuan in 1995 and 1996) . It appears that the turnover tax has replaced the hand-over of the contract system as the "preferred dividend" to the sole shareholder, the Beijing City government.
A number of businesses have been sold or substantially restructured and a number of expansion plans have been dropped since 1995. Much of the change has stemmed from the failure of Shougang to obtain approval from the central government to expand steel production outside Beijing. e.g. the Qilu and Liuzhou projects have been dropped. A reassessment of Shougang's strategy recognised that the Corporation's development was limited by several factors, e.g. poor products mix, low profitability of second-tier companies, a heavy debt burden, and a large number of surplus workers. 7 Shougang had borrowed heavily to finance the ambitious diversification programme in the early 1990s. In 1996, Shougang's total debt was 18.4 billion yuan, of which 79% was short-term. 8 In The Beijing City government has set a limit of eight million tons of steelmaking capacity at Shougang, in line with its goal of changing the production structure of Beijing towards knowledge-based and high value-added products (Luo, 1998) . Shougang plans to improve the application of computers to automate the production process, improve production efficiency and reduce the emission of pollutants. Moreover, steel products are increasingly to be manufactured in semi-finished or finished form, according to the customers' specifications. The general strategy is to improve the whole production and marketing processes from the selection and preparation of iron ores to the distribution and after-sales services. Shougang aims to raise the share of high value-added steel products from a mere 12% in 1997, to 30% in 2005, and over 60% in 2010. By 2000, it intends to raise average annual productivity per employee to more than 209,000 yuan (over US$25,000) and 380 tons/year.
• Continued overseas business development: By 1996, Shougang's overseas assets were valued at US$1.6 billion, amounting to 24% of the Group's total assets and its foreign sales amounted to US$1.03 billion, amounting to 24% of its total revenue. Through China Shougang International Trading and Engineering Corporation (CSITEC), Shougang aims to further develop the export markets and generate more revenues in Southeast Asia, South America and Africa. It has already exported steel-making facilities to Asian less developed countries (LDCs), and it is beginning to penetrate the African market by completing a blast furnace project in Zimbabwe. Since completing the purchase, Shougang has invested US$150 million to process the iron ore at the Hierro Mine (Peru) so that it meets pollution regulations in the DCs. The upgrading of product quality has enabled the mine to export iron ore to Brazil, the US, Japan and South Korea. The mine made annual pre-tax profits of US$3 million since 1997. It is planned to restructure the Hierro mine and float the company on the US and Canadian stock markets.
To conclude, Shougang is one of the four steel companies that have been selected by the Chinese government to constitute the core of the future Chinese steel industry. The contract system at Shougang unleashed an extraordinary entrepreneurial energy and enormous reinvestment and modernisation programmes in the formerly traditional state-run steel plant. It constituted an important transitional step away from the complete absence of entrepreneurial incentives under the command economy. However, the contract system was a crude instrument for allocating the stream of revenue stemming from the assets that Shougang operated. In the post-contract system, Shougang's autonomy on its production structure and product marketing has increased substantially. Shougang is moving towards a new epoch, with the plans to float parts of the steel business on the stock market, expand the total volume of steel output and increase the production of high value-added products.
The Chinese Pharmaceutical Industry in Reform
From the mid-1980s onward, the government relaxed state controls over the pharmaceuticals industry, allowing competition to develop gradually among suppliers. However, China's large, old-established SOEs remained tightly controlled by the government, with production and sales tasks for its main products. These plants mainly produce relatively capital-intensive upstream intermediate pharmaceuticals, especially out-of-patent antibiotics, as well as producing generic, low margin final products, e.g. penicillin and aspirin. Many of these were on a downward spiral, with old equipment, a high debt-asset ratio, low salaries, poor housing and research conditions. Under the new agreement with the GLD in 1991, Nanfang was to be placed directly under its supervision and would henceforth make its hand-over of post-tax profits to the GLD (Li & Li, 1995, p. 64-65) . Under the "deal", Nanfang was granted complete operational autonomy, subject only to requiring the approval of the GLD for very large-scale investments. Nanfang was later to become the core enterprise in a newly formed conglomerate, the Sanjiu Enterprise Group. The hand-over to the GLD was a fairly stable fixed amount, totalling around 70-80 million yuan/year. Consequently, the proportion of post-tax profits handed over fell from 20% in 1991 to 12% in 1997, alongside rapid growth in Sanjiu's total profits. However, the GLD could still require Sanjiu to make a large ad hoc hand-over, e.g. in 1995, the 23 million yuan "contribution" to the building of a new meeting hall for the GLD in Beijing. The second part of the deal was that Nanfang would take over the GLD's 35 (mainly loss-making) enterprises in Shenzhen. Between 1992 and 1994, Sanjiu injected 200 million yuan into these enterprises. Sanjiu controlled its subordinate companies in the same way as Sanjiu was supervised by the GLD. However, the second and third-tier companies did not possess the same level of independence (Li & Li, 1995) . The existing general managers and department heads in the second and third-tier enterprises had to compete openly for their old jobs. Existing managers who stayed on in their jobs had to undergo extensive retraining and were dismissed if they did not pass their examinations or performed unsatisfactorily.
Core business in Chinese medicines
Product selection and marketing
Although none of the pioneers in Nanfang had any experience of business, they knew instinctively that they needed to "get close to the market" to be successful. 12 The Chinese pattern of food consumption leads to widespread stomach acidity due to an excess of glucose arising from high grain consumption. For years, Zhao had accumulated over 10,000 patient histories involving stomach treatment with Sanjiu Weitai ("Stomach Healthy 999"). Sanjiu Weitai was thought by Nanfang's leaders to have a large potential market. In 1995, Sanjiu Weitai was still Nanfang's best-selling drug, accounting for 70% of Sanjiu's total revenue from pharmaceuticals and 37% of the total national market for stomach medicines.
Its closest competitor in this field was Lizhu (Zhuhai), with 18% national market share. 13 Zhao Xinxian frankly acknowledged: "like Coca-Cola, Nanfang's products are simple, and our competitors' products are not fundamentally different from ours." Consequently, advertising is an important aspect of the growth of the firm. Nanfang built its own advertising firm, and hired film stars and staff from Chinese film studios to make their advertisements. 14 , 1997, p. 67; 1998, p. 8) .
As controls over the pharmaceuticals distribution system relaxed in the late 
Modernisation
Nanfang was the first firm in China to produce Chinese medicines in a Western fashion. From 1991, Nanfang conducted a two-year comprehensive modernisation programme to meet the "Good Manufacturing Standards" (GMP), the strict standards followed by the US Food and Drug Administration (FDA).
Modernisation of equipment, meticulous quality control and recording procedures were essential to meet the strict standards of GMP. Nanfang invested 70 million yuan from its own funds in upgrading its equipment, largely through imports.
Despite this large investment, the debt-assets ratio at Nanfang was 15%, and 46%
for Sanjiu. By 1997, the ratio had risen to 41% for Nanfang and 60% for the whole Group, still relatively low compared to other Chinese firms. 15 By the mid-1990s, all the main pieces of production equipment were of 1990s vintage. The main items are as follows:
• NF-B automatic traditional Chinese medicine extraction line
• Automatic packing line for granules
• Capsule production line
• Ointment production line
• Plastic container packing line
• Tablet production line
• Quality checking centre
Meeting the GMP standards also necessitated high worker skill levels.
Existing cadres and production workers were given training courses in GMP standards, and if they failed to meet the standards they were either dismissed or removed from the production lines. Its core staff of around 500 cadres mostly have university science degrees. They have to attend compulsory computer and foreign language training courses. Cadres are strongly encouraged to participate in the part-time MBA programme in Nanfang. The high technical and linguistic skills achieved by Nanfang's cadres were important in enabling Nanfang to select appropriate equipment and use it effectively. The main imported pieces of equipment were made according to Nanfang's engineering specifications.
After rising from 96 employees in 1987 when the plant opened, to 1,163 in 1990, the number remained at around the same level thereafter. The gross value of output per employee rose from 115,000 yuan in 1987 to 328,000 yuan in 1990, reaching 1,468,000 yuan in 1994. This was achieved through ploughing back a large fraction of retained profits into the purchase of new equipment. Indeed, the number of workers on the production line had fallen from 1,500 (including temporary workers at peak periods) to just 110 in 1998.
Management and employment structure
Zhao Xinxian and his five army colleagues each earned around 140-150 yuan/month during the two years it took to construct Nanfang, which was 50% of their incomes at the Army Hospital. Much of their time was spent physically being involved in the construction of the plant. Their slogans were: "production first, life later" (xianshengchan, houshenghuo) and "hard and arduous struggle" (jianku fendou). The army background helped them to sustain their spirit and discipline during this tough and highly uncertain phase of business building. During these years a close bond built up among this group, which still remains at the centre of the firm's leading cadres in the mid-1990s. The core of the Nanfang business is around 240 managerial cadres, almost all of whom are highly educated. Within these is an inner group of managers who control the destiny of the business. Of this group, about half a dozen are key founder members of business, led by Zhao Xinxian. Zhao is a powerful motivator, who was able to weld together a strong management team and provide a vision and sense of purpose to the firm. All of the 900 ordinary workers at the main plant are either temporary or contract workers, with a very high turnover rate, almost 40% per annum.
The difference between the "inner" and the "outer" firm is symbolised by the wage system put into effect after Nanfang shifted to being directly supervised by the GLD. Ordinary workers were now paid according to a regular manual workers' wage scale. In 1995, their monthly wages ranged from 500-1,800 yuan.
The cadres were remunerated according to the 1:18 wage scale. In 1995, actual wages paid to cadres ranged from 900 yuan/month to 4,000 yuan/month for Zhao.
Moreover, Sanjiu allocates 15% of the post-tax profits as bonuses on a scale of 1:3. A significant share of Nanfang's retained profits has been ploughed into building high quality housing in the plant's semi-suburban location. All the permanent employees at Nanfang live in company apartments. Rents are nominal, a "few tens" of yuan/month. Open market rents for equivalent apartments in Shenzhen are around 3,000-4,000 yuan/month. This amounts to a large addition to the real value of employees' incomes, and constitutes a major incentive to remain in employment at Nanfang. There is little difference in the size or quality of apartments among Nanfang's permanent workers, so the subsidy is a fairly egalitarian one.
Other pharmaceutical businesses
In the mid-1990s, Sanjiu began the policy of "Second Enterprise Establishment" (erci chuangye) the goal of which was to acquire pharmaceutical enterprises in the remote but resource rich western region, and turn them around through introducing the Sanjiu management system, brand name and marketing network. A leading example of this is the Ya'an Pharmaceutical Plant in Sichuan.
It was acquired by Sanjiu in 1995, with Sanjiu taking an 80% ownership share for 17 million yuan. Sanjiu upgraded the manufacturing facilities substantially.
Within a year, the gross value of production in Ya'an increased four-fold to 80 million yuan and its post-tax profits increased ten-fold to 15 million yuan. In 1997, Ya'an's gross value of output reached 200 million yuan and its post-tax profits reached 64.91 million yuan, which was more than 60 times higher than the best record before the acquisition (SEG, 1998, pp. 4-7) . In fact, it ranked second (Nanfang was first) in the amount of profits turned over to Sanjiu in 1997 (SJB, 8 & 15 April 1998 .
In 1993, Sanjiu set up a JV, the Sanjiu Pharmaceutical Company, to produce Western medicines. The main product was Locekin (Ceftriaxon), which had sales of 22.5 million yuan in 1994, still a small fraction (2%) of the value of Sanjiu's total sales. This is the vehicle that Sanjiu intends to use to raise funds on the stock markets to expand Nanfang's capacity to produce anti-arthritis and anti-cancer drugs. As the central government regulation is that the local shareholder (Sanjiu) must control the majority share in the listed company, Sanjiu repurchased 60.9% of the shares from seven overseas shareholders after the State Council's Security Committee approved its application to list on the Chinese stock market.
Non-core businesses
Although Sanjiu was the leading producer of traditional Chinese medicines, it was highly dependent on a single, non-patented product: Sanjiu
Weitai. In the absence of patented drugs, it had not been able to establish a strong market position in other (Chinese) medicines. Moreover, other institutions, such as local governments, are supporting their own local "champions", e.g. Yangwei chongji is included in the government's free medicine programme, while Nanfang's Sanjiu Weitai is not.
Even after it had become China's leading pharmaceutical firm, Sanjiu was Zhao Xinxian put this bluntly: "We must diversify, because we simply cannot match the multinationals in proprietary technology."
A key aspect of the 1992 "deal" struck by Zhao Xinxian was that Nanfang would merge with the GLD's 35 plants in Shenzhen. These included firms in construction, clothing, trade, printing and packaging, taxi renting, tourism and a hotel. At a stroke, Nanfang had become a highly diversified conglomerate. Since 1991, Sanjiu has acquired 50 enterprises in 20 provinces, of which one-half were non-pharmaceuticals. By 1997, the share of the non-core businesses had risen to over 63% of Sanjiu's total output value.
The trend in Sanjiu's take-overs was towards establishing a controllingshare in the firms which it acquired. However, Sanjiu usually invites local governments to hold 10-20% share of the acquired enterprises. This not only lowers the financial risk in the take-over, but also secures political support from the local governments (SJB, 25 February 1998) . A good example of its M&As is the Shijiazhuang Beer Factory in Shijiazhuang city in Hebei province. This lossmaking firm was acquired in 1995. It had around 3,000 employees and was administered by the local government. Sanjiu advertised for an expert in the beer industry and replaced the existing manager. Sanjiu developed the idea of providing surplus workers with the incentive of a lump-sum severance payment (qiansanfei). With the help of Sanjiu's marketing network and trademark, Shijiazhuang was able to re-pay the 17 million yuan loans from Sanjiu, and turned over three million yuan in profits to the core company in 1997 (SEG, 1998, p. 6) .
Despite the addition of a wide range of unrelated businesses to the portfolio, the best performers were still pharmaceuticals firms in 1997-1998.
Although the core plant, Nanfang, accounted for only 30% of Sanjiu's total assets and 6% of Sanjiu's total employees in 1997, and generated only 37% of Sanjiu's sales value, it still accounted for one-half of the entire Sanjiu Group's pre-tax profits. Nanfang consistently achieved a profit rate on sales of between 16-22%, while for other businesses, the rate was only around 6-12%. Moreover, the two other enterprises apart from Nanfang with pre-tax profits of over 50 million yuan in 1997 were pharmaceutical firms, and three of the four enterprises with pre-tax profits of 25-50 million yuan in 1997 were also pharmaceutical enterprises (SEG, 1998, pp. 4-5; SJB, 6 May 1998).
Business structure and business strategy
By 1998, Sanjiu had evolved into a very different firm from the late 1980s.
Zhao Xinxian was still the most powerful and authoritative person in Sanjiu.
Under his leadership, the Group had developed a Decision Management
Committee in charge of devising major strategic decisions for the Group ( Figure   2 ). The Strategic Decision "Think-Tank" Committee, which incorporates a number of Chinese economists and intellectuals, provides numerous suggestions on the development of business strategy. In 1998, the Company had nine major divisions, which all reported to the General Manager, Zhao Xinxian.
PLACE FIGURE 2 ABOUT HERE
The Group's business interests were divided into two categories: the general commercial companies and the eight major industries (Figure 2 ). The pharmaceuticals sector (including medical health care) was the core (first pillar) business in the Group. After 1996, Sanjiu's second pillar business was the food and beverage sector (which developed to complement the hotel and tourism sectors). The other six major industries of Sanjiu were wine manufacturing (including beers), agriculture (including the manufacturing of agricultural machinery, chemical fertiliser and cultivation), tourism (including hotels), real estate (including the construction of infrastructure and provision of construction materials), trading (including franchised dealers and retailers) and automobiles (including the manufacturing of automobiles and spare parts).
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In terms of assets and employment, the "core" of pharmaceuticals had shrunk drastically relative to non-core business. Instead of a firm of around 1,200 employees, mostly employed at a single site, the Group now owned 70 second-tier enterprises, with a total of around 3,000 employees in the first and second-tier firms, whose wages were mostly paid by the core firm and had their "file" (dangan) lodged at Nanfang. It also had a third, and much larger, tier of employees, who were not paid their wages by the core firm and whose "file" was not deposited at the firm's headquarters. However, they were working directly for Sanjiu. These included over 1,000 pharmaceutical salespeople working on commission, around 3,000 employees in the Sanjiu hotel chain, several thousand employees in merged businesses, and "several tens of thousands" of workers in the construction firm. By 1998, the total number of employees working for the Group may have been well over 50,000.
Even before the onset of the East Asian financial crisis, Sanjiu was reevaluating the strategy of diversification, influenced by difficulties encountered with its increasingly diversified business portfolio. The East Asian crisis has explicitly stimulated an even sharper re-evaluation of the company's strategic direction. It has determined to re-focus on its core businesses in pharmaceuticals and closely related businesses, e.g. food and beverages. Sanjiu feels that traditional Chinese medicines have a lot in common with the production and marketing of these products: they share some common elements of R&D, require high quality control over ingredients, close attention to packaging quality, need an effective sales network, and depend heavily on brand imagery. Marketing is at the centre of product success.
To become a modern pharmaceuticals company and the largest traditional
Chinese medicine manufacturer in the world within five years, Sanjiu has revised its business strategies. The major features are as follows (SEG, 1998, pp. 3-20; SJB, 25 February 1997, 22 April 1998):
• Raising its in-house R&D investment, and developing co-operative and joint R&D projects with more than 30 medical schools and hospitals in China. At present, Nanfang is engaged in the development of 16 new patented drugs, including an anti-AIDS drug and a drug for diabetes.
• Building two FDA approved Chinese medicines manufacturing centres, one in Shenzhen and one in Sichuan. Sanjiu is also improving its production capacities of Western medicine by fostering Shenzhen Gosun Pharmaceutical Corporation to become the largest manufacturing base of cephalosporins antibiotic products in China.
• Giving close attention to the importance of intellectual property rights, including those for Chinese medicines, which is still a grey area of domestic and international laws.
• Improving the way in which it develops and uses the Sanjiu trademark and its 59 registered brand names.
• Raising funds from the stock market through subsidiaries, and being strongly committed to raising capital and transferring technology through international JVs that are consistent with Sanjiu's re-formulated business goals.
• Ensuring 100% of its workforce has attained professional high school qualification or above. In 1998, Sanjiu introduced the "profits-related promotion mechanism" in order to develop a group of talented senior managers.
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• Attempting to establish and strengthen the responsibility and risk-monitoring mechanism within each affiliated enterprise. According to the new guidelines devised in 1997, M&A targets were all to be compatible with the renewed focus on pharmaceuticals and closely related businesses. The first-tier core enterprise was not be involved directly in any new M&A to lower its debtassets ratio. M&A deals were only to be undertaken by second or third-tier enterprises if they were financially sound and the targets had marketable products and potential for further growth. In 1997, Sanjiu evaluated over 700 potential take-over targets, but, based on these criteria, acquired only 20 enterprises.
• Introducing a trial experiment with an employees' stock-holding scheme and strengthening the sense of belonging and sense of awareness about the importance of efficiency among Sanjiu employees.
Under the new policies, Sanjiu abandoned the attempt to make automobiles a "second pillar industry" and suspended investment in the sector. It closed down or sold off 16 poorly-managed third-tier companies. It integrated and reshuffled the assets of those companies which had recorded losses for two consecutive years or large losses in a single year (12 out of the total of 71 enterprises in the Sanjiu Group were loss-making in 1997) (SEG, 1998, pp. 5-6) .
To conclude, a number of arguments can be advanced to explain Sanjiu's exceptional growth and modernisation. It enjoyed special advantages because of its location in Shenzhen SEZ. As it started from scratch, it was not burdened by the restructuring introduced in many long-established SOEs. Furthermore, it had the support of the Army's GLD. 18 None of these arguments is wholly convincing, however. The initial growth of Sanjiu was based on the traditional Chinese medicines it produced. This sector is characterised more by entrepreneurial skills, product choice, quality control, marketing, and brand imagery than advanced technology. In pursuit of growth, the Group acquired diversified businesses that it was unable to run effectively. It lost valuable financial and human capital in attempting to turn the businesses around, detracting from its ability to develop its core business in which it had the highest competence. Moreover, it was in danger of diluting the valuable brand name that it had painstakingly and highly successfully built up in the preceding period. Returning to its core competencies in pharmaceuticals marked a radical re-evaluation of its business strategy.
Implications and Conclusions
The experiences of Shougang and Sanjiu not only have profound implications for the future development of the Chinese steel and pharmaceutical industries, but also on the reform of large SOEs in China. The major findings and the implications of this paper are as follows:
• Institutional first movers: The communist "planning" system intentionally destroyed the competitive firm. Instead, the whole nation, in practice the relevant ministries, became the firm, with the enterprise essentially the passive recipient of instructions from bureaucrats. A central part of the transition from a command system to a market-based system was the re-creation of the competitive firm as the basic form of business institution. This can come in different shapes and sizes, and the reasons that explain this are complex and are often specific to the firm concerned. When increased operational independence was granted to SOEs, some responded more quickly than others to construct a competitive institutional structure. Those that were able to do so rapidly improved their market position: Shougang rose rapidly from seventh largest to be the third largest steel manufacturer in China, and Nanfang rose even more rapidly from non-existence to be number two in the pharmaceutical sector. A striking feature of TNCs has been their relative stability of position once they have achieved large size. Those large firms that are able to take the lead in the "Chinese big business race" may well be able to maintain their position for a long time to come. • Organisational capabilities: Both Shougang and Sanjiu made effective use of institutions inherited from the pre-reform period. A central proposition of the "transition orthodoxy" about how to transform communist economies was that the pre-reform communist institutions should be destroyed (Nolan, 1995) . It was thought by almost everyone that they were implacably opposed to reform, their interests irreconcilable with the market economy, their members incapable of turning towards the market. The experience of Shougang and Sanjiu suggests rather that the CCP and the PLA possessed a rich legacy of organisational and motivational skills. Even old Party cadres and army officers, such as Zhou Guanwu, were able to make the transition to the market economy when given the correct incentive structure. A middle-aged one, like Zhao Xinxian, made the transition with ease. Indeed, the lifetime experience of such people, thinking strategically and mobilising people in complex institutions, was an invaluable skill for the construction of a powerful marketoriented business organisation. The experience of Shougang and Sanjiu challenged not only the traditional theory of the firm, but also the liberal neoclassical ideology which was battling for supremacy in China.
• Entrepreneurship: It is highly debatable whether entrepreneurship can be considered an independent variable explaining the success and failure of national economies. National entrepreneurial capability is almost always seen best as a reflection of deeper socio-economic processes. However, entrepreneurship clearly matters in considering the changes in fortune of large capitalist firms, let alone small ones. A good or bad appointment as Chief Executive Officer (CEO) makes a great deal of difference to the performance of a firm. It is impossible not to be struck by the fact that successful large Chinese firms emerging from the communist system, such as Shougang and Nanfang, often have highly effective CEOs. The reasons they came to occupy those positions typically are complex matters of business history. Moreover, most rapid technological up-grading in Shougang and Sanjiu was conducted in the early 1990s, which coincided with a property speculation boom in which most Chinese firms participated, suggesting that entrepreneurs at Shougang and Sanjiu worked for growth within their industries rather than for short-term profit maximisation. Furthermore, the formal ownership structures at Shougang and Sanjiu prior to 1996 and 1997 respectively might appear to be incompatible with effective business behaviour in the sense that they are still SOEs. The intermediary bodies with controls over those assets, namely the Beijing municipal government and the GLD, appear to have little understanding of how to stimulate effective business performance in their subordinate units. The subordinate enterprises, Shougang and Sanjiu, paid a substantial share of profits in "dividends" to their respective sole shareholders, the Beijing municipal government and the GLD. However, the "profits hand-over" was not fundamentally different from the hand-over of dividends by the managers of a capitalist family-owned firm to the family that owns it. The enterprise management was left with a high degree of managerial autonomy, including the business strategy on M&A. The main reason for Shougang and Sanjiu's success is not special help from the government or the PLA, but rather the fact that the leadership used their autonomy to construct a highly effective business organisation.
• M&As: Shougang and Sanjiu both grew rapidly through M&As in the absence of privatisation and a developed stock market. There were three main causes of this process. First, the government required powerful SOEs, such as Shougang and Sanjiu, to help resolve the problems of loss-making enterprises by re-organising their business structure, changing management methods and advancing technology. To this extent it was a "top-down" process. Examples of this were Shougang's merger with the 13 loss-making "Third Front" military enterprises, and Sanjiu's merger with the 100-odd GLD's enterprises in Shenzhen. Second, it was due to "bottom-up" pressure from a successful, emerging large firm. A large part of both Shougang and Sanjiu's M&As came from their own initiative, though they always required state mediation and sanction. China is not unique in this. Typically, M&As among large capitalist firms are closely involved with the highly political process of obtaining approval from the relevant government anti-monopoly apparatus, both national and international. Shougang and Sanjiu's mergers used methods familiar under capitalism, whereby some firms acquire other loss-making firms believing that they have the capability to "dig out hidden value", change their organisational structure and transform them into profitable entities. Bankruptcy, plant closure or mass redundancy are not the only ways to resolve the problems of loss-making enterprises. A fast-growing reforming economy, in the process of developing a business structure from scratch provided rich opportunities for such business behaviour. Furthermore, M&As are especially powerful methods of advancing business capabilities in a transitional economy, since business and technical skills are not so widely available as in an advanced economy. The merger process led by capable firms such as Shougang and Sanjiu with advanced technological and management skills, can have a powerful positive externality effect, spreading business capability more rapidly than would otherwise be the case. Thirdly, the merger movement is due to opportunism by large firms such as Shougang and Sanjiu in response to property rights becoming more formalised and ownership becoming more tangible. They use their bargaining power with local governments to enhance the number of enterprises owned by them, in order to be able to increase the size of their firm. To some unknown degree, this is a "positioning" process, in anticipation of a possible future move towards even more concrete private property rights being permitted over former SOEs. Through merger, a large state firm can acquire potential future assets of great value, including the land on which the firm is located. In principle, a merger between two SOEs today, could bring considerable personal gain for the employees at some future point.
• Political and social constraints: The experience of Shougang and Sanjiu also suggests that excessive diversification, partly through administrative-mediated M&As and partly due to the political and social constraints on making massive downsizing in employment, may contribute to their long-term competitive disadvantage. Both Shougang and Sanjiu have only limited business skills in those non-core diversified business activities. They were unable to generate sufficient economies of scale, encountered fierce competition, and leaked valuable financial and human capital in attempting to turn the businesses around, distracting them from developments in the businesses in which they had the highest competence. There are already warning signs of the difficulties this has posed for Shougang and Sanjiu as a significant proportion of profits generated from their core businesses are offset by the loss-making non-core businesses. In the case of Shougang, this proportion reached a staggering 87% in 1997 (SG, 1998, pp. 3-4) . 19 It is striking that the most successful steel 
